Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Cette étude évalue la valeur pronostique de mutations du proto-oncogène NOTCH1 chez les patients atteints d'une leucémie lymphocytaire chronique (539 cas)
Analysis of the chronic lymphocytic leukemia (CLL) coding genome has recently disclosed that the NOTCH1 proto-oncogene is recurrently mutated at CLL presentation. Here we assessed the prognostic role of NOTCH1 mutations in CLL. Two series of newly diagnosed CLL were utilized as training (n=309) and validation (n=230) cohorts. NOTCH1 mutations occurred in 11.0% and 11.3% CLL of the training and validation series, respectively. In the training series, NOTCH1 mutations led to a 3.77 fold increase in the hazard of death and to shorter overall survival (OS) (p<.001). Multivariate analysis selected NOTCH1 mutations as an independent predictor of OS after controlling for confounding clinical and biological variables. The independent prognostic value of NOTCH1 mutations was externally confirmed in the validation series. The poor prognosis conferred by NOTCH1 mutations was attributable, at least in part, to shorter treatment-free survival and higher risk of Richter transformation. Although NOTCH1 mutated patients were devoid of TP53 disruption in >90% cases in both training and validation series, the OS predicted by NOTCH1 mutations was similar to that of TP53 mutated/deleted CLL. NOTCH1 mutations are an independent predictor of CLL OS, tend to be mutually exclusive with TP53 abnormalities and identify cases with a dismal prognosis.
Blood , résumé, 2011